Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients
Glypican-3 (GPC-3) is a heparin sulfate proteoglycan located extracellularly and anchored to the cell membrane of transformed hepatocytes. GPC-3 is not expressed in normal or cirrhotic liver tissue but is overexpressed in hepatocellular carcinoma (HCC). Because of this, GPC-3 is one of the most impo...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/13/10922 |
_version_ | 1797591564278562816 |
---|---|
author | Montalbano Mauro Perricone Ugo Zachary Walton Shirafkan Ali Cristiana Rastellini Luca Cicalese |
author_facet | Montalbano Mauro Perricone Ugo Zachary Walton Shirafkan Ali Cristiana Rastellini Luca Cicalese |
author_sort | Montalbano Mauro |
collection | DOAJ |
description | Glypican-3 (GPC-3) is a heparin sulfate proteoglycan located extracellularly and anchored to the cell membrane of transformed hepatocytes. GPC-3 is not expressed in normal or cirrhotic liver tissue but is overexpressed in hepatocellular carcinoma (HCC). Because of this, GPC-3 is one of the most important emerging immunotargets for treatment and as an early detection marker of HCC. To determine if GPC-3 domains associated with serum small extracellular vesicles (sEVs) could be used as an HCC diagnostic marker, we predicted in silico GPC-3 structural properties and tested for the presence of its full-length form and/or cleaved domains in serum sEVs isolated from patients with HCC. Structural analysis revealed that the Furin cleavage site of GPC-3 is exposed and readily accessible, suggesting the facilitation of GPC-3 cleavage events. Upon isolation of sEVs from both hepatocytes, culture media and serum of patients with HCC were studied for GPC-3 content. This data suggests that Furin-dependent GPC-3 cleaved domains could be a powerful tool for detection of initial stages of HCC and serve as a predictor for disease prognosis. |
first_indexed | 2024-03-11T01:39:14Z |
format | Article |
id | doaj.art-926e60df30004bc685a32b5bf465f791 |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-11T01:39:14Z |
publishDate | 2023-06-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-926e60df30004bc685a32b5bf465f7912023-11-18T16:45:29ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-06-0124131092210.3390/ijms241310922Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma PatientsMontalbano Mauro0Perricone Ugo1Zachary Walton2Shirafkan Ali3Cristiana Rastellini4Luca Cicalese5Department of Neurology, University of Texas Medical Branch, Galveston, TX 77555-5302, USAMolecular Informatics Group, Fondazione Ri.MED., 90133 Palermo, ItalyJohn Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555-5302, USARutgers Health, Department of Cardiac Surgery, New Brunswick, NJ 08901, USADepartment of Surgery, University of Texas Medical Branch, Galveston, TX 77555-5302, USADepartment of Neurobiology, University of Texas Medical Branch, Galveston, TX 77555-5302, USAGlypican-3 (GPC-3) is a heparin sulfate proteoglycan located extracellularly and anchored to the cell membrane of transformed hepatocytes. GPC-3 is not expressed in normal or cirrhotic liver tissue but is overexpressed in hepatocellular carcinoma (HCC). Because of this, GPC-3 is one of the most important emerging immunotargets for treatment and as an early detection marker of HCC. To determine if GPC-3 domains associated with serum small extracellular vesicles (sEVs) could be used as an HCC diagnostic marker, we predicted in silico GPC-3 structural properties and tested for the presence of its full-length form and/or cleaved domains in serum sEVs isolated from patients with HCC. Structural analysis revealed that the Furin cleavage site of GPC-3 is exposed and readily accessible, suggesting the facilitation of GPC-3 cleavage events. Upon isolation of sEVs from both hepatocytes, culture media and serum of patients with HCC were studied for GPC-3 content. This data suggests that Furin-dependent GPC-3 cleaved domains could be a powerful tool for detection of initial stages of HCC and serve as a predictor for disease prognosis.https://www.mdpi.com/1422-0067/24/13/10922hepatocellular carcinomaGlypican-3small extracellular vesicleserum marker |
spellingShingle | Montalbano Mauro Perricone Ugo Zachary Walton Shirafkan Ali Cristiana Rastellini Luca Cicalese Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients International Journal of Molecular Sciences hepatocellular carcinoma Glypican-3 small extracellular vesicle serum marker |
title | Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients |
title_full | Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients |
title_fullStr | Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients |
title_full_unstemmed | Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients |
title_short | Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma Patients |
title_sort | glypican 3 gpc 3 structural analysis and cargo in serum small extracellular vesicles of hepatocellular carcinoma patients |
topic | hepatocellular carcinoma Glypican-3 small extracellular vesicle serum marker |
url | https://www.mdpi.com/1422-0067/24/13/10922 |
work_keys_str_mv | AT montalbanomauro glypican3gpc3structuralanalysisandcargoinserumsmallextracellularvesiclesofhepatocellularcarcinomapatients AT perriconeugo glypican3gpc3structuralanalysisandcargoinserumsmallextracellularvesiclesofhepatocellularcarcinomapatients AT zacharywalton glypican3gpc3structuralanalysisandcargoinserumsmallextracellularvesiclesofhepatocellularcarcinomapatients AT shirafkanali glypican3gpc3structuralanalysisandcargoinserumsmallextracellularvesiclesofhepatocellularcarcinomapatients AT cristianarastellini glypican3gpc3structuralanalysisandcargoinserumsmallextracellularvesiclesofhepatocellularcarcinomapatients AT lucacicalese glypican3gpc3structuralanalysisandcargoinserumsmallextracellularvesiclesofhepatocellularcarcinomapatients |